Oslo - April 21, 2023: EXACT Therapeutics AS , a clinical stage biopharmaceutical company with a mission to enhance the
therapeutic efficacy of medicines through. | April 21, 2023
Oslo (Norway), 31 August 2022 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim first-half year 2022 results. Please find enclosed the report and presentation. Highlights Corporate The
PCI Biotech interim first-half year 2022 results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Oslo (Norway), 11 May 2022 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim Q1 2022 results. Please find enclosed the report and presentation. Highlights fimaVacc The
EXACT Therapeutics AS (“EXACT-Tx”, Euronext Growth: EXTX), a clinical stage precision health company utilising Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, announces that its Board of Directors has today appointed Dr Per Walday as Chief Executive Officer (CEO). A successful senior executive .